Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Easter Island quarry reveals how Polynesians made enigmatic stone statues - 2Find Your Internal Culinary expert: Cooking Strategies and Recipes
- 3How did humans evolve, and will we evolve more?
- 4Instructions to Perform Fundamental Upkeep on Your Slam 1500.
- 5Understanding Preschool Projects: Cultivating Abilities and Advancement
- Figure out How to Get the Best Open Record Rewards
- Tens of thousands protest as far-right AfD forms new youth group
- The Main 20 Gaming Control center Ever
- Instructions to Utilize Your Brain science Certification to Work on Corporate Culture
- Vote in favor of the pasta that makes good dieting pleasant!
- 2024 Manual for Light Extravagance Room Feel: What's Moving
- Top 15 Web-based Entertainment Stages for Individual Marking
- From Specialist to Proficient Picture taker: Individual Triumphs
- The Job of a Migration Legal advisor: How They Can Help You
